# Lung Cancer Registry

> **NCT04654364** · — · RECRUITING · sponsor: **Arbeitsgemeinschaft medikamentoese Tumortherapie** · enrollment: 500 (estimated)

## Conditions studied

- Lung Cancer
- NSCLC Stage IV
- NSCLC, Stage III
- SCLC, Extensive Stage
- SCLC, Limited Stage

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04654364
- **Lead sponsor:** Arbeitsgemeinschaft medikamentoese Tumortherapie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-18
- **Primary completion:** 2030-08
- **Final completion:** 2030-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654364, "Lung Cancer Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04654364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*